Comparison of Two D-Dimers Dosing Techniques

Comparison of Two D-Dimers Dosing Techniques : LIATEST DDI PLUS (STAGO) Versus VIDAS D-DIMERS (BIOMERIEUX)

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03972839

Acronym

COMPADDI

Enrollment

3027

Registered

2019-06-04

Start date

2019-07-01

Completion date

2021-01-01

Last updated

2021-06-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Blood Coagulation Disorder

Keywords

Blood Coagulation, DDimers

Brief summary

Study of the possibility of substitution of the automated STAGO D-Dimers method with the semi-automated VIDAS method, which is more expensive, longer to implement and requires the use of a dedicated automaton.

Detailed description

To compare D-Dimer assay techniques in the exclusion of VTE (Thromboembolic Venous Disease):• BIOMERIEUX: D-Dimers VIDAS (considered as reference technique)• STAGO: D-Di PlusOn a population of patients recruited in Brest for a period of 1 year: patients for whom a dosage of VIDAS D-dimers is prescribed (approximately 3700 patients)

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

* Patients for whom a dosage of D-Dimers VIDAS is prescribed in the context of a suspicion of VTE at Brest CHRU. * No opposition formulated.

Exclusion criteria

* Curative dose anticoagulant treatment whatever the indication, * Pregnancy in progress, * Follow-up at 3 months not possible, * Patient refusing to participate

Design outcomes

Primary

Measure	Time frame	Description
Biomerieux D-Dimer level	at the inclusion	quantification of Biomerieux D-Dimer level (VIDAS)
Stago D-Dimer level	at the inclusion	quantification of Biomerieux D-Dimer level (STAGO)

Countries

France

Outcome results